Literature DB >> 15466379

Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.

Margarida Lima1, Julia Almeida, Andrés García Montero, Maria dos Anjos Teixeira, Maria Luís Queirós, Ana Helena Santos, Ana Balanzategui, Alexandra Estevinho, Maria del Cármen Algueró, Paloma Barcena, Sónia Fonseca, Maria Luís Amorim, José Manuel Cabeda, Luciana Pinho, Marcos Gonzalez, Jesus San Miguel, Benvindo Justiça, Alberto Orfão.   

Abstract

Indolent natural killer (NK) cell lymphoproliferative disorders include a heterogeneous group of patients in whom persistent expansions of mature, typically CD56(+), NK cells in the absence of any clonal marker are present in the peripheral blood. In the present study we report on the clinical, hematological, immunophenotypic, serological, and molecular features of a series of 26 patients with chronic large granular NK cell lymphocytosis, whose NK cells were either CD56(-) or expressed very low levels of CD56 (CD56(-/+dim) NK cells), in the context of an aberrant activation-related mature phenotype and proved to be monoclonal using the human androgen receptor gene polymerase chain reaction-based assay. As normal CD56(+) NK cells, CD56(-/+dim) NK cells were granzyme B(+), CD3(-), TCRalphabeta/gammadelta(-), CD5(-), CD28(-), CD11a(+bright), CD45RA(+bright), CD122(+), and CD25(-) and they showed variable and heterogeneous expression of both CD8 and CD57. Nevertheless, they displayed several unusual immunophenotypic features. Accordingly, besides being CD56(-/+dim), they were CD11b(-/+dim) (heterogeneous), CD7(-/+dim) (heterogeneous), CD2(+) (homogeneous), CD11c(+bright) (homogeneous), and CD38(-/+dim) (heterogeneous). Moreover, CD56(-/+dim) NK cells heterogeneously expressed HLA-DR. In that concerning the expression of killer receptors, CD56(-/+dim) NK cells showed bright and homogeneous CD94 expression, and dim and heterogeneous reactivity for CD161, whereas CD158a and NKB1 expression was variable. From the functional point of view, CD56(-/+dim) showed a typical Th1 pattern of cytokine production (interferon-gamma(+), tumor necrosis factor-alpha(+)). From the clinical point of view, these patients usually had an indolent clinical course, progression into a massive lymphocytosis with lung infiltration leading to death being observed in only one case. Despite this, they frequently had associated cytopenias as well as neoplastic diseases and/or viral infections. In summary, we describe a unique and homogeneous group of monoclonal chronic large granular NK cell lymphocytosis with an aberrant activation-related CD56(-/+dim)/CD11b(-/+dim) phenotype and an indolent clinical course, whose main clinical features are related to concomitant diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466379      PMCID: PMC1618630          DOI: 10.1016/s0002-9440(10)63373-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  65 in total

1.  CD3(-) large granular lymphocyte leukemia with clonal rearrangement of the gamma and beta genes of the T-cell receptor.

Authors:  R Manteiga; L Florensa; F Solé; M Prat; C Besses; S Woessner
Journal:  Haematologica       Date:  2000-08       Impact factor: 9.941

Review 2.  Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.

Authors:  A Orfao; G Schmitz; B Brando; A Ruiz-Arguelles; G Basso; R Braylan; G Rothe; F Lacombe; F Lanza; S Papa; P Lucio; J F San Miguel
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

3.  Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.

Authors:  R Nash; P McSweeney; R Zambello; G Semenzato; T P Loughran
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

4.  Chronic natural killer cell lymphocytosis.

Authors:  A Tefferi
Journal:  Leuk Lymphoma       Date:  1996-01

5.  Large Granular Lymphocyte Leukemia.

Authors: 
Journal:  Cancer Control       Date:  1998-01       Impact factor: 3.302

6.  Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia.

Authors:  T P Loughran; T Coyle; M P Sherman; G Starkebaum; G D Ehrlich; F W Ruscetti; B J Poiesz
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

7.  Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia.

Authors:  A B Gelb; M van de Rijn; D P Regula; J P Cornbleet; O W Kamel; D S Horoupian; M L Cleary; R A Warnke
Journal:  Hum Pathol       Date:  1994-09       Impact factor: 3.466

8.  Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.

Authors:  Masataka Satoh; Noritaka Oyama; Hitoshi Akiba; Mikio Ohtsuka; Keiji Iwatsuki; Fumio Kaneko
Journal:  Eur J Dermatol       Date:  2002 Jul-Aug       Impact factor: 3.328

9.  Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia.

Authors:  T P Loughran; R Zambello; R Ashley; J Guderian; M Pellenz; G Semenzato; G Starkebaum
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

10.  Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.

Authors:  G E Nichols; D E Normansell; M E Williams
Journal:  Mod Pathol       Date:  1994-10       Impact factor: 7.842

View more
  20 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  Predictors of Subclinical Inflammatory Obesity: Plasma Levels of Leptin, Very Low-Density Lipoprotein Cholesterol and CD14 Expression of CD16+ Monocytes.

Authors:  Fernanda Leite; Ângela Leite; Ana Santos; Margarida Lima; Joselina Barbosa; Marco Cosentino; Laura Ribeiro
Journal:  Obes Facts       Date:  2017-07-22       Impact factor: 3.942

3.  Two-compartment model of NK cell proliferation: insights from population response to IL-15 stimulation.

Authors:  Yun M Zhao; Anthony R French
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

Review 4.  Natural killer-cell neoplasms.

Authors:  John P Greer; Claudio A Mosse
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

Review 5.  Update on the World Health Organization classification of peripheral T-cell lymphomas.

Authors:  Hilary M O'Leary; Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2009-10       Impact factor: 3.952

6.  Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

7.  Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients.

Authors:  E Poullot; R Zambello; F Leblanc; B Bareau; E De March; M Roussel; M L Boulland; R Houot; A Renault; T Fest; G Semenzato; T Loughran; T Lamy
Journal:  Ann Oncol       Date:  2014-08-05       Impact factor: 32.976

8.  The human androgen receptor X-chromosome inactivation assay for clonality diagnostics of natural killer cell proliferations.

Authors:  Michaël Boudewijns; Jacques J M van Dongen; Anton W Langerak
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

9.  Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infections.

Authors:  Bradley W Ornstein; Elaise B Hill; Theresa L Geurs; Anthony R French
Journal:  J Infect Dis       Date:  2012-11-21       Impact factor: 5.226

10.  High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

Authors:  Anne-Sophie Chretien; Raynier Devillier; Samuel Granjeaud; Charlotte Cordier; Clemence Demerle; Nassim Salem; Julia Wlosik; Florence Orlanducci; Laurent Gorvel; Stephane Fattori; Marie-Anne Hospital; Jihane Pakradouni; Emilie Gregori; Magali Paul; Philippe Rochigneux; Thomas Pagliardini; Mathieu Morey; Cyril Fauriat; Nicolas Dulphy; Antoine Toubert; Herve Luche; Marie Malissen; Didier Blaise; Jacques A Nunès; Norbert Vey; Daniel Olive
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.